NRIX
Price
$9.46
Change
+$0.35 (+3.84%)
Updated
Sep 3 closing price
Capitalization
723.21M
35 days until earnings call
ZYME
Price
$14.14
Change
+$0.13 (+0.93%)
Updated
Sep 3 closing price
Capitalization
1.07B
Interact to see
Advertisement

NRIX vs ZYME

Header iconNRIX vs ZYME Comparison
Open Charts NRIX vs ZYMEBanner chart's image
Nurix Therapeutics
Price$9.46
Change+$0.35 (+3.84%)
Volume$1.07M
Capitalization723.21M
Zymeworks
Price$14.14
Change+$0.13 (+0.93%)
Volume$715.18K
Capitalization1.07B
NRIX vs ZYME Comparison Chart in %
Loading...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZYME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NRIX vs. ZYME commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRIX is a Buy and ZYME is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (NRIX: $9.11 vs. ZYME: $14.01)
Brand notoriety: NRIX and ZYME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRIX: 147% vs. ZYME: 144%
Market capitalization -- NRIX: $723.21M vs. ZYME: $1.07B
NRIX [@Biotechnology] is valued at $723.21M. ZYME’s [@Biotechnology] market capitalization is $1.07B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRIX’s FA Score shows that 1 FA rating(s) are green whileZYME’s FA Score has 0 green FA rating(s).

  • NRIX’s FA Score: 1 green, 4 red.
  • ZYME’s FA Score: 0 green, 5 red.
According to our system of comparison, ZYME is a better buy in the long-term than NRIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRIX’s TA Score shows that 4 TA indicator(s) are bullish while ZYME’s TA Score has 5 bullish TA indicator(s).

  • NRIX’s TA Score: 4 bullish, 5 bearish.
  • ZYME’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, both NRIX and ZYME are a bad buy in the short-term.

Price Growth

NRIX (@Biotechnology) experienced а -4.41% price change this week, while ZYME (@Biotechnology) price change was -5.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +16.10%, and the average quarterly price growth was +32.67%.

Reported Earning Dates

NRIX is expected to report earnings on Oct 09, 2025.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZYME($1.07B) has a higher market cap than NRIX($723M). ZYME YTD gains are higher at: -4.303 vs. NRIX (-51.645). ZYME has higher annual earnings (EBITDA): -69.77M vs. NRIX (-212.78M). NRIX has more cash in the bank: 486M vs. ZYME (281M). ZYME has less debt than NRIX: ZYME (18.7M) vs NRIX (51.9M). ZYME has higher revenues than NRIX: ZYME (123M) vs NRIX (88.4M).
NRIXZYMENRIX / ZYME
Capitalization723M1.07B68%
EBITDA-212.78M-69.77M305%
Gain YTD-51.645-4.3031,200%
P/E RatioN/AN/A-
Revenue88.4M123M72%
Total Cash486M281M173%
Total Debt51.9M18.7M278%
FUNDAMENTALS RATINGS
ZYME: Fundamental Ratings
ZYME
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
62
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NRIXZYME
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 13 days ago
82%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZYME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FAFCX36.06N/A
N/A
Fidelity Advisor Financials C
FDVLX14.48N/A
N/A
Fidelity Value
AXVNX19.14-0.10
-0.52%
Acclivity Small Cap Value N
SDVGX17.32-0.10
-0.57%
Sit Dividend Growth I
ITYAX67.16-0.60
-0.89%
Invesco Technology A

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been closely correlated with KYMR. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
-2.46%
KYMR - NRIX
68%
Closely correlated
-1.24%
IDYA - NRIX
60%
Loosely correlated
+3.79%
DNLI - NRIX
58%
Loosely correlated
+1.18%
CRNX - NRIX
56%
Loosely correlated
+7.45%
BEAM - NRIX
55%
Loosely correlated
-0.31%
More

ZYME and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZYME has been loosely correlated with CRNX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ZYME jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZYME
1D Price
Change %
ZYME100%
-5.40%
CRNX - ZYME
49%
Loosely correlated
+7.45%
NRIX - ZYME
49%
Loosely correlated
-2.46%
ABEO - ZYME
48%
Loosely correlated
+0.29%
XNCR - ZYME
47%
Loosely correlated
+5.17%
ELVN - ZYME
47%
Loosely correlated
+3.06%
More